 | • レポートコード：GIR-2104Z08512 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、限局性自己免疫疾患診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。限局性自己免疫疾患診断の種類別市場規模（多発性硬化症、1型糖尿病、橋本甲状腺炎、特発性血小板減少性紫斑病、その他）、用途別市場規模（病院、診療所、研究所、実験室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・限局性自己免疫疾患診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Hoffmann-La Roche Ltd、Siemens Healthineers、Abbott Laboratories、Beckman Coulter, Inc.、SQI Diagnostics、Quest Diagnostics、EUROIMMUN AG、AESKU.Diagnostics GmbH & Co. KG、INOVA Diagnostics, Inc.、Crescendo Bioscience, Inc.、bioMerieux SA、Bio-Rad Laboratories, Inc.、Hemagen Diagnostics, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：多発性硬化症、1型糖尿病、橋本甲状腺炎、特発性血小板減少性紫斑病、その他 ・用途別分析2016年-2026年：病院、診療所、研究所、実験室 ・限局性自己免疫疾患診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・限局性自己免疫疾患診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・限局性自己免疫疾患診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・限局性自己免疫疾患診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・限局性自己免疫疾患診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Localized Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Localized Autoimmune Disease Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Localized Autoimmune Disease Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Localized Autoimmune Disease Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Multiple Sclerosis
Type 1 Diabetes
Hashimoto’s Thyroiditis
Idiopathic Thrombocytopenic Purpura
Others
Market segment by Application, can be divided into
Hospital
Clinic
Research Institute
Laboratories
Market segment by players, this report covers
Hoffmann-La Roche Ltd
Siemens Healthineers
Abbott Laboratories
Beckman Coulter, Inc.
SQI Diagnostics
Quest Diagnostics
EUROIMMUN AG
AESKU.Diagnostics GmbH & Co. KG
INOVA Diagnostics, Inc.
Crescendo Bioscience, Inc.
bioMerieux SA
Bio-Rad Laboratories, Inc.
Hemagen Diagnostics, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Localized Autoimmune Disease Diagnostics
1.2 Classification of Localized Autoimmune Disease Diagnostics by Type
1.2.1 Overview: Global Localized Autoimmune Disease Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Type in 2020
1.2.3 Multiple Sclerosis
1.2.4 Type 1 Diabetes
1.2.5 Hashimoto’s Thyroiditis
1.2.6 Idiopathic Thrombocytopenic Purpura
1.2.7 Others
1.3 Global Localized Autoimmune Disease Diagnostics Market by Application
1.3.1 Overview: Global Localized Autoimmune Disease Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.4 Global Localized Autoimmune Disease Diagnostics Market Size & Forecast
1.5 Global Localized Autoimmune Disease Diagnostics Market Size and Forecast by Region
1.5.1 Global Localized Autoimmune Disease Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Localized Autoimmune Disease Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Localized Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Localized Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Localized Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Localized Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Localized Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Localized Autoimmune Disease Diagnostics Market Drivers
1.6.2 Localized Autoimmune Disease Diagnostics Market Restraints
1.6.3 Localized Autoimmune Disease Diagnostics Trends Analysis
2 Company Profiles
2.1 Hoffmann-La Roche Ltd
2.1.1 Hoffmann-La Roche Ltd Details
2.1.2 Hoffmann-La Roche Ltd Major Business
2.1.3 Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Product and Solutions
2.1.4 Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.2 Siemens Healthineers
2.2.1 Siemens Healthineers Details
2.2.2 Siemens Healthineers Major Business
2.2.3 Siemens Healthineers Localized Autoimmune Disease Diagnostics Product and Solutions
2.2.4 Siemens Healthineers Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Siemens Healthineers Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Localized Autoimmune Disease Diagnostics Product and Solutions
2.3.4 Abbott Laboratories Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Beckman Coulter, Inc.
2.4.1 Beckman Coulter, Inc. Details
2.4.2 Beckman Coulter, Inc. Major Business
2.4.3 Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
2.4.4 Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beckman Coulter, Inc. Recent Developments and Future Plans
2.5 SQI Diagnostics
2.5.1 SQI Diagnostics Details
2.5.2 SQI Diagnostics Major Business
2.5.3 SQI Diagnostics Localized Autoimmune Disease Diagnostics Product and Solutions
2.5.4 SQI Diagnostics Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 SQI Diagnostics Recent Developments and Future Plans
2.6 Quest Diagnostics
2.6.1 Quest Diagnostics Details
2.6.2 Quest Diagnostics Major Business
2.6.3 Quest Diagnostics Localized Autoimmune Disease Diagnostics Product and Solutions
2.6.4 Quest Diagnostics Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Quest Diagnostics Recent Developments and Future Plans
2.7 EUROIMMUN AG
2.7.1 EUROIMMUN AG Details
2.7.2 EUROIMMUN AG Major Business
2.7.3 EUROIMMUN AG Localized Autoimmune Disease Diagnostics Product and Solutions
2.7.4 EUROIMMUN AG Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 EUROIMMUN AG Recent Developments and Future Plans
2.8 AESKU.Diagnostics GmbH & Co. KG
2.8.1 AESKU.Diagnostics GmbH & Co. KG Details
2.8.2 AESKU.Diagnostics GmbH & Co. KG Major Business
2.8.3 AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Product and Solutions
2.8.4 AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AESKU.Diagnostics GmbH & Co. KG Recent Developments and Future Plans
2.9 INOVA Diagnostics, Inc.
2.9.1 INOVA Diagnostics, Inc. Details
2.9.2 INOVA Diagnostics, Inc. Major Business
2.9.3 INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
2.9.4 INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 INOVA Diagnostics, Inc. Recent Developments and Future Plans
2.10 Crescendo Bioscience, Inc.
2.10.1 Crescendo Bioscience, Inc. Details
2.10.2 Crescendo Bioscience, Inc. Major Business
2.10.3 Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
2.10.4 Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Crescendo Bioscience, Inc. Recent Developments and Future Plans
2.11 bioMerieux SA
2.11.1 bioMerieux SA Details
2.11.2 bioMerieux SA Major Business
2.11.3 bioMerieux SA Localized Autoimmune Disease Diagnostics Product and Solutions
2.11.4 bioMerieux SA Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 bioMerieux SA Recent Developments and Future Plans
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Bio-Rad Laboratories, Inc. Details
2.12.2 Bio-Rad Laboratories, Inc. Major Business
2.12.3 Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
2.12.4 Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.13 Hemagen Diagnostics, Inc.
2.13.1 Hemagen Diagnostics, Inc. Details
2.13.2 Hemagen Diagnostics, Inc. Major Business
2.13.3 Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
2.13.4 Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Hemagen Diagnostics, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Localized Autoimmune Disease Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Localized Autoimmune Disease Diagnostics Players Market Share
3.2.2 Top 10 Localized Autoimmune Disease Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Localized Autoimmune Disease Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Localized Autoimmune Disease Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Localized Autoimmune Disease Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Localized Autoimmune Disease Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
6.2 North America Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
6.3 North America Localized Autoimmune Disease Diagnostics Market Size by Country
6.3.1 North America Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
7.2 Europe Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
7.3 Europe Localized Autoimmune Disease Diagnostics Market Size by Country
7.3.1 Europe Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Localized Autoimmune Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Region (2016-2026)
8.3.2 China Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
9.2 South America Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
9.3 South America Localized Autoimmune Disease Diagnostics Market Size by Country
9.3.1 South America Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Localized Autoimmune Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Localized Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Localized Autoimmune Disease Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Localized Autoimmune Disease Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Localized Autoimmune Disease Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Localized Autoimmune Disease Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 7. Hoffmann-La Roche Ltd Major Business
Table 8. Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Product and Solutions
Table 9. Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 11. Siemens Healthineers Major Business
Table 12. Siemens Healthineers Localized Autoimmune Disease Diagnostics Product and Solutions
Table 13. Siemens Healthineers Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories Localized Autoimmune Disease Diagnostics Product and Solutions
Table 17. Abbott Laboratories Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beckman Coulter, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter, Inc. Major Business
Table 20. Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 21. Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. SQI Diagnostics Corporate Information, Head Office, and Major Competitors
Table 23. SQI Diagnostics Major Business
Table 24. SQI Diagnostics Localized Autoimmune Disease Diagnostics Product and Solutions
Table 25. SQI Diagnostics Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 27. Quest Diagnostics Major Business
Table 28. Quest Diagnostics Localized Autoimmune Disease Diagnostics Product and Solutions
Table 29. Quest Diagnostics Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. EUROIMMUN AG Corporate Information, Head Office, and Major Competitors
Table 31. EUROIMMUN AG Major Business
Table 32. EUROIMMUN AG Localized Autoimmune Disease Diagnostics Product and Solutions
Table 33. EUROIMMUN AG Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AESKU.Diagnostics GmbH & Co. KG Corporate Information, Head Office, and Major Competitors
Table 35. AESKU.Diagnostics GmbH & Co. KG Major Business
Table 36. AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Product and Solutions
Table 37. AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. INOVA Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. INOVA Diagnostics, Inc. Major Business
Table 40. INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 41. INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Crescendo Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Crescendo Bioscience, Inc. Major Business
Table 44. Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 45. Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. bioMerieux SA Corporate Information, Head Office, and Major Competitors
Table 47. bioMerieux SA Major Business
Table 48. bioMerieux SA Localized Autoimmune Disease Diagnostics Product and Solutions
Table 49. bioMerieux SA Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Bio-Rad Laboratories, Inc. Major Business
Table 52. Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 53. Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Hemagen Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Hemagen Diagnostics, Inc. Major Business
Table 56. Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 57. Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Localized Autoimmune Disease Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 59. Global Localized Autoimmune Disease Diagnostics Revenue Share by Players (2019-2021)
Table 60. Breakdown of Localized Autoimmune Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Localized Autoimmune Disease Diagnostics Players Head Office, Products and Services Provided
Table 62. Localized Autoimmune Disease Diagnostics Mergers & Acquisitions in the Past Five Years
Table 63. Localized Autoimmune Disease Diagnostics New Entrants and Expansion Plans
Table 64. Global Localized Autoimmune Disease Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 65. Global Localized Autoimmune Disease Diagnostics Revenue Share by Type (2016-2021)
Table 66. Global Localized Autoimmune Disease Diagnostics Revenue Forecast by Type (2021-2026)
Table 67. Global Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2021)
Table 68. Global Localized Autoimmune Disease Diagnostics Revenue Forecast by Application (2021-2026)
Table 69. North America Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Localized Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Localized Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Localized Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Localized Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Localized Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Localized Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Localized Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Localized Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Localized Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Localized Autoimmune Disease Diagnostics Picture
Figure 2. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Type in 2020
Figure 3. Multiple Sclerosis
Figure 4. Type 1 Diabetes
Figure 5. Hashimoto's Thyroiditis
Figure 6. Idiopathic Thrombocytopenic Purpura
Figure 7. Others
Figure 8. Localized Autoimmune Disease Diagnostics Revenue Market Share by Application in 2020
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Research Institute Picture
Figure 12. Laboratories Picture
Figure 13. Global Localized Autoimmune Disease Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Localized Autoimmune Disease Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 16. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Region in 2020
Figure 17. North America Localized Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Localized Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Localized Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Localized Autoimmune Disease Diagnostics Market Drivers
Figure 22. Localized Autoimmune Disease Diagnostics Market Restraints
Figure 23. Localized Autoimmune Disease Diagnostics Market Trends
Figure 24. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 25. Siemens Healthineers Recent Developments and Future Plans
Figure 26. Abbott Laboratories Recent Developments and Future Plans
Figure 27. Beckman Coulter, Inc. Recent Developments and Future Plans
Figure 28. SQI Diagnostics Recent Developments and Future Plans
Figure 29. Quest Diagnostics Recent Developments and Future Plans
Figure 30. EUROIMMUN AG Recent Developments and Future Plans
Figure 31. AESKU.Diagnostics GmbH & Co. KG Recent Developments and Future Plans
Figure 32. INOVA Diagnostics, Inc. Recent Developments and Future Plans
Figure 33. Crescendo Bioscience, Inc. Recent Developments and Future Plans
Figure 34. bioMerieux SA Recent Developments and Future Plans
Figure 35. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 36. Hemagen Diagnostics, Inc. Recent Developments and Future Plans
Figure 38. Global Localized Autoimmune Disease Diagnostics Revenue Share by Players in 2020
Figure 39. Localized Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Localized Autoimmune Disease Diagnostics Revenue Market Share in 2020
Figure 41. Global Top 10 Players Localized Autoimmune Disease Diagnostics Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Localized Autoimmune Disease Diagnostics Revenue Share by Type in 2020
Figure 44. Global Localized Autoimmune Disease Diagnostics Market Share Forecast by Type (2021-2026)
Figure 45. Global Localized Autoimmune Disease Diagnostics Revenue Share by Application in 2020
Figure 46. Global Localized Autoimmune Disease Diagnostics Market Share Forecast by Application (2021-2026)
Figure 47. North America Localized Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 48. North America Localized Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 49. North America Localized Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 50. United States Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Localized Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 54. Europe Localized Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 55. Europe Localized Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 56. Germany Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Localized Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Localized Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 64. China Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Localized Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 71. South America Localized Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 72. South America Localized Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Localized Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Localized Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の全身性自己免疫疾患診断市場 2021：企業別、地域別、種類・用途別 The Systemic Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年） The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific. In terms of geography, the Americas led the …
- 世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Disease Diagnosis Market The global Autoimmune Disease Diagnosis market size is projected to reach US$ 4227.9 million by 2026, from US$ 2983.8 million in 2019, at a CAGR of 5.0% during 2021-2026. With industry-standard accuracy in analysis and high dat…
- 世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Disease Therapeutics Market The global Autoimmune Disease Therapeutics market size is projected to reach US$ 116550 million by 2026, from US$ 98660 million in 2019, at a CAGR of 2.4% during 2021-2026. With industry-standard accuracy in analysis and hig…
- 世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors. Market Analysis and Insights: Global Autoimmune Disease Treatment Market The glob…